ResearcherUniversitat de ValènciaActive in the last 2 years
Marina Garcés‐Albir
Matched on ORCID iD 0000-0001-9474-6521; OpenAlex author ID A5009734373. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 6
- 3D-PANC study protocol: Is three-dimensional imaging technology superior to computed tomography for assessing the response to neoadjuvant treatment in patients… Co-author DOI 10.1016/j.cireng.2025.800256↗
- Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gassur.2024.01.018↗
- ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast pr… Co-author DOI 10.1016/j.trsl.2024.05.003↗
- Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. Co-author DOI 10.3390/cancers13050994↗
- Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre. Co-author DOI 10.1136/esmoopen-2020-000929↗
- Borderline resectable pancreatic cancer. Challenges and controversies. Co-author DOI 10.1016/j.ctrv.2018.06.006↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dimitri Dorcaratto · 4 shared papers, 2018–2026 · strength 0.68
- Paper 3D-PANC study protocol: Is three-dimensional imaging technology superior to computed tomography for assessing the respo… DOI 10.1016/j.cireng.2025.800256↗
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcom… DOI 10.1136/esmoopen-2020-000929↗
- Luis Sabater-Orti · 5 shared papers, 2018–2024 · strength 0.61
- Paper Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreati… DOI 10.1016/j.gassur.2024.01.018↗
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. DOI 10.3390/cancers13050994↗
- Marisol Huerta · 4 shared papers, 2018–2024 · strength 0.44
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. DOI 10.3390/cancers13050994↗
- Paper Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcom… DOI 10.1136/esmoopen-2020-000929↗
- Andrès M.R. Cervantes · 4 shared papers, 2018–2024 · strength 0.44
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. DOI 10.3390/cancers13050994↗
- Paper Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcom… DOI 10.1136/esmoopen-2020-000929↗
- Susana Roselló · 4 shared papers, 2018–2024 · strength 0.44
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. DOI 10.3390/cancers13050994↗
- Paper Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcom… DOI 10.1136/esmoopen-2020-000929↗
- Noelia Tarazona · 3 shared papers, 2020–2024 · strength 0.37
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. DOI 10.3390/cancers13050994↗
- Paper Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcom… DOI 10.1136/esmoopen-2020-000929↗
- Clara Alfaro‐Cervelló · 3 shared papers, 2020–2024 · strength 0.37
- Paper ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and iden… DOI 10.1016/j.trsl.2024.05.003↗
- Paper Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. DOI 10.3390/cancers13050994↗
- Paper Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcom… DOI 10.1136/esmoopen-2020-000929↗
- Mario Serradilla Martin · 1 shared paper, 2024 · strength 0.16
- Silvia Carbonell‐Morote · 1 shared paper, 2024 · strength 0.16
- Fernando Rotellar · 1 shared paper, 2024 · strength 0.16
- José Manuel Ramia · 1 shared paper, 2024 · strength 0.16
- Gerardo Blanco‐Fernández · 1 shared paper, 2024 · strength 0.16
- Maider Ibarrola‐Villava · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.